Fermenta Biotech
Fermenta Biotech Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Fermenta Biotech Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Fermenta Biotech Ltd trades at a P/E of 10.50× and P/B of 2.38×.
Valuation
Profitability
Growth
Financial Health
Fermenta Biotech Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Fermenta Biotech Ltd, switchable between annual and quarterly views, consolidated or standalone.
Fermenta Biotech Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹979.17 Cr and reported EPS of ₹29.60.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 405 | 293 | 377 | 399 | 350 | 336 | 469 | 525 |
| Other Income | 12 | 12 | 8 | 8 | 8 | 11 | 12 | 22 |
| Total Income | 417 | 305 | 386 | 407 | 358 | 347 | 481 | 548 |
| Cost of Goods Sold (COGS) | 92 | 79 | 134 | 153 | 154 | 130 | 147 | 192 |
| Gross Profit | 312 | 214 | 243 | 245 | 196 | 206 | 322 | 333 |
| +Operating Expenses | 164 | 149 | 161 | 184 | 178 | 177 | 212 | 234 |
| EBITDA | 149 | 65 | 82 | 61 | 18 | 28 | 110 | 100 |
| +Non-Operating Expenses | 33 | 34 | 38 | 43 | 21 | 34 | 38 | 40 |
| Profit Before Tax (PBT) | 129 | 43 | 52 | 27 | -52 | -10 | 83 | 96 |
| +Tax Expense | 11 | -16 | 9 | 12 | 2 | 14 | 7 | 26 |
| Profit After Tax (PAT) | 117 | 60 | 43 | 15 | -54 | -24 | 76 | 70 |
| Earnings Per Share (EPS) | 45.28 | 20.22 | 14.45 | 5.12 | -18.20 | -8.16 | 25.96 | 23.87 |
| Diluted Shares Outstanding (Nos.) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| +Additional Disclosures | 372 | 343 | 468 | 533 | 533 | 479 | 544 | 644 |
| Sales Growth % | — | -27.61 | 28.79 | 5.63 | -12.19 | -4.08 | 39.87 | 11.92 |
| YoY Sales Growth % | — | -27.61 | 28.79 | 5.63 | -12.19 | -4.08 | 39.87 | 11.92 |
| Material Cost % | 26 | 36 | 38 | 33 | 32 | 23 | 25 | 28 |
| Employee Cost % | 13 | 17 | 15 | 16 | 17 | 17 | 14 | 16 |
| Other Cost % | 27 | 34 | 27 | 30 | 34 | 35 | 31 | 29 |
| OPM % | 37 | 22 | 22 | 15 | 5 | 8 | 23 | 19 |
| Tax % | 8 | -37 | 18 | 44 | -3 | -143 | 8 | 27 |
| Profit Growth % | — | -49.33 | -28.54 | -64.59 | -455.59 | 55.17 | 418.23 | -8.05 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 137 | 50 | 61 | 36 | -10 | 3 | 86 | 78 |
Fermenta Biotech segment analysis: revenue and profit mix.
Disclosed business segments at Fermenta Biotech with their share of revenue and profit, switchable between consolidated and standalone reporting.
Fermenta Biotech discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Fermenta Biotech Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Fermenta Biotech Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Trim if P/E re-rates above 14. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 20%. The operating engine is no longer compounding capital efficiently.
Fermenta Biotech Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Fermenta Biotech Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Fermenta Biotech Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Fermenta Biotech Ltd — derived from the live tape, not yesterday's close.
Fermenta Biotech Ltd last traded at ₹338.35 with an intraday range of ₹332–₹340.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹338.35| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 359.70 | +21.35 | +6.31% |
| R3 | 350.90 | +12.55 | +3.71% |
| R2 | 345.85 | +7.50 | +2.22% |
| R1 | 342.10 | +3.75 | +1.11% |
| PIVOT | 337.05 | -1.30 | -0.38% |
| CURRENT | 338.35 | — | — |
| S1 | 315.70 | -22.65 | -6.69% |
| S2 | 324.50 | -13.85 | -4.09% |
| S3 | 328.25 | -10.10 | -2.99% |
| S4 | 333.30 | -5.05 | -1.49% |
FERMENTA is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: 333.8 ~ 337.5
Trading Above opening range, showing Bullishness
Fermenta Biotech Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Fermenta Biotech Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Fermenta Biotech Ltd stood at 44.3% of traded volume, against a 20-day average of 67.5%.
Fermenta Biotech announcements: results, concalls, ratings, M&A.
Filings Fermenta Biotech sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
No filings or concall transcripts on record.
Fermenta Biotech dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Fermenta Biotech has declared, sequenced by announce and record date.
Fermenta Biotech corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Fermenta Biotech Ltd: business, sector, key facts.
What Fermenta Biotech Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Fermenta Biotech Ltd is a listed Indian equity, listed as NSE: FERMENTA, BSE: 506414.
Questions investors ask about Fermenta Biotech Ltd (FERMENTA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Fermenta Biotech Ltd (FERMENTA)?
The current share price of Fermenta Biotech Ltd (FERMENTA) is ₹338.35. Today, the stock has gained by ₹8.30 (2.51%), trading in a range of ₹332 to ₹340.8. The stock opened at ₹335 with a trading volume of 28,639 shares.
02Is Fermenta Biotech Ltd stock a good investment for long-term?
Fermenta Biotech Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹979.17 crores, P/E ratio of 10.50, ROE of 24.90%, and ROCE of 23.00%. The dividend yield stands at 0.79%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Fermenta Biotech Ltd stock?
The 52-week high price of Fermenta Biotech Ltd (FERMENTA) is ₹0, while the 52-week low is ₹0. Currently trading at ₹338.35, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Fermenta Biotech Ltd stock at the current price?
Whether to buy Fermenta Biotech Ltd stock at ₹338.35 depends on multiple factors. The stock is currently trading with a P/E ratio of 10.50 and P/B ratio of 2.38. Today's performance shows a gain of 2.51%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Fermenta Biotech Ltd and when is the next dividend?
Fermenta Biotech Ltd offers a dividend yield of 0.79%, which means for every ₹100 invested at the current price of ₹338.35, you can expect to receive approximately ₹0.79 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Fermenta Biotech Ltd?
Fermenta Biotech Ltd's key financial metrics include: P/E Ratio: 10.50, P/B Ratio: 2.38, ROE: 24.90%, ROCE: 23.00%, Dividend Yield: 0.79%, EPS: ₹29.60, Book Value: ₹133, and Debt-to-Equity: 0.29. The company's market cap stands at ₹979.17 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Fermenta Biotech Ltd stock performing today in the market?
Fermenta Biotech Ltd stock opened at ₹335 and is currently trading at ₹338.35, showing a gain of ₹8.30 (2.51%). The intraday high is ₹340.8 and low is ₹332. The trading volume stands at 28,639 shares, indicating moderate market participation today.
08What is the P/E ratio of Fermenta Biotech Ltd and what does it indicate?
Fermenta Biotech Ltd has a Price-to-Earnings (P/E) ratio of 10.50, which means investors are willing to pay ₹10.50 for every ₹1 of earnings. With an EPS of ₹29.60, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Fermenta Biotech Ltd (FERMENTA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- AHCL (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top quality scorecard stocksScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy